Makoto Jitsuoka
Mo Sci Corporation (United States)(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Regulation of Appetite and Obesity, Chemical Synthesis and Analysis, Mast cells and histamine
Most-Cited Works
- → A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice(2006)76 cited
- → Characterization of Neuropeptide Y (NPY) Y5 Receptor-Mediated Obesity in Mice: Chronic Intracerebroventricular Infusion ofd-Trp34NPY(2003)60 cited
- → (9S)-9-(2-Hydroxy-4,4-dimethyl-6-oxo-1-cyclohexen-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one, a Selective and Orally Active Neuropeptide Y Y5 Receptor Antagonist(2008)57 cited
- → Total Synthesis of (+)-7-Deoxypancratistatin and (+)-7-Deoxy-trans-dihydronarciclasine(1996)51 cited
- → Inverse agonist histamine H3 receptor PET tracers labelled with carbon‐11 or fluorine‐18(2009)44 cited
- → A Pair-Feeding Study Reveals That a Y5 Antagonist Causes Weight Loss in Diet-Induced Obese Mice by Modulating Food Intake and Energy Expenditure(2006)42 cited
- → Sepantronium Bromide (YM155) Enhances Response of Human B-Cell Non-Hodgkin Lymphoma to Rituximab(2012)31 cited
- → Discovery of Tetrasubstituted Imidazolines as Potent and Selective Neuropeptide Y Y5 Receptor Antagonists: Reduced Human Ether-a-go-go Related Gene Potassium Channel Binding Affinity and Potent Antiobesity Effect(2009)26 cited
- → Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists(2008)17 cited
- → Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists(2009)17 cited